Oncofertility Perspectives for Girls with Cancer.

Fertility preservation Ovarian tissue cryopreservation Ovarian tissue transplantation Pediatric oncology

Journal

Journal of pediatric and adolescent gynecology
ISSN: 1873-4332
Titre abrégé: J Pediatr Adolesc Gynecol
Pays: United States
ID NLM: 9610774

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 03 12 2021
revised: 03 03 2022
accepted: 18 03 2022
pubmed: 1 4 2022
medline: 13 10 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Infertility is a serious early, as well as late, effect of childhood cancer treatment. If addressed in a timely manner at diagnosis, fertility preservation measures can be taken, preferably before the start of cancer treatment. However, pediatric oncologists might remain reluctant to offer counseling on fertility-preservation methods, although infrastructure to freeze ovarian tissue has become available and is currently considered standard care for pre- and postpubertal girls at high risk of gonadal damage. More importantly, risk factors have been identified for cancer treatment-related impairment of gonadal function, and the first successful pregnancies have been reported after autotransplanted ovarian tissue, which has been harvested from children. Additionally, great progress has been made in the field of ex vivo maturation of oocytes in frozen ovarian tissue, which provides opportunities for those at risk of ovarian micrometastasis. Hence, it is time to counsel girls at risk and make every effort to cryopreserve their ovarian tissue, now more than ever before.

Identifiants

pubmed: 35358705
pii: S1083-3188(22)00184-X
doi: 10.1016/j.jpag.2022.03.005
pii:
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-526

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no potential conflicts of interest.

Auteurs

M E Madeleine van der Perk (MEM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: m.e.m.vanderperk@prinsesmaximacentrum.nl.

Anne-Lotte L F van der Kooi (ALF)

Department of Obstetrics and Gynecology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands.

Annelies M E Bos (AME)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.

Simone L Broer (SL)

Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.

Margreet A Veening (MA)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Jeanette van Leeuwen (J)

Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands.

Hanneke M van Santen (HM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

Wendy van Dorp (W)

Department of Obstetrics and Gynecology, IJsselland Ziekenhuis, Rotterdam, the Netherlands.

Marry M van den Heuvel-Eibrink (MM)

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH